Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
11/2005
11/01/2005US6960587 Piperido(1,2-a)piperazine-1,4-dione derivatives fused to a 5-7 membered ring at the 7-8 position; cGMP-specific PDE inhibitors; treatment of cardiovascular disorders and erectile dysfunction.
11/01/2005US6960586 Having a steroid C17,20-lyase inhibitory activity; useful as prophylactic or therapeutic agent for prostate and breast cancers
11/01/2005CA2383351C Xanthine derivatives as selective antagonists of a2b adenosine receptors
10/2005
10/27/2005WO2005099760A1 Solid pharmaceutical preparation
10/27/2005WO2005099671A2 Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
10/27/2005US20050240017 5-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-5,11-dihydro-6-oxa-12-thia-dibenzo[a,f]azulen-2-ol; 13-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-7,13-dihydro-12-oxa-benzo[4,5]cyclohepta[1,2-a]naphthalen-3-ol or derivatives or salts; for alleviating symptoms of estrogen deprivation, including bone loss
10/27/2005US20050239851 Substituted benzoxazoles as estrogenic agents
10/27/2005US20050239835 controlling weight gain; 1-(1-amino-2-phenylethylcarbonyl)-4-cyclohexylpiperidine compounds
10/27/2005US20050239789 2-(9-bromo-3,4,10,10a-tetrahydro-1H-pyrazino[1,2-a]indol-2-yl)-cyclobutanone; treating disorders of the central nervous system, damage to the central nervous system, cardiovascular disorders, gastrointestinal disorders, diabetes insipidus, obesity and sleep apnea
10/27/2005US20050239773 1-[9-(3-Phenyl-allyl)-3,9 diaza-bicyclo[4.2.1]non-3-yl]-propan-1-one; analgesic; great selectivity to mu receptor; analgesic; pain relief, drug dependence, alcoholism; side effect reduction
10/27/2005US20050239169 Nucleotide sequences coding seladin-1polypeptide for use in treatment and prevention of alzheimer's disease
10/27/2005US20050239166 Polynucleotides encoding human secreted protein, ZZP1
10/27/2005US20050239040 System for producing mammalian pre-embryo and stem cell having better quality; co-culturing of oocytes and spermatozoa in lowered oxygen tension
10/27/2005US20050238737 Use of one or more shogaol(s) as an aphrodisiac
10/27/2005CA2563689A1 Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
10/27/2005CA2562391A1 Solid pharmaceutical preparation
10/27/2005CA2561014A1 Thioamide derivatives as progesterone receptor modulators
10/26/2005EP1589100A1 Transcriptional activator
10/26/2005EP1589033A1 Antibody and use thereof
10/26/2005EP1501859B1 17a-FLUOROALKYL-11BETA-BENZALDOXIME-STEROIDS, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS CONTAINING SAID STEROIDS AND THE USE THEREOF IN THE PRODUCTION OF MEDICAMENTS
10/26/2005EP1397354B1 Imidazole-2-carboxamide derivatives as raf kinase inhibitors
10/26/2005EP1381607B1 Novel pyridine- and cyclohexenyl-comprising pyrrolobenzodiazepine-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists
10/26/2005EP1363641B1 Progestin co-micronized with a surfactant, pharmaceutical composition comprising the same, methods for making same and uses thereof
10/26/2005EP1289965B1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
10/26/2005EP1107762B1 Use of misoprostol or/and misoprostol acid for preparing drug in order to cure sexual dysfunction in women
10/26/2005EP1098870B1 Nitrate salt of Cetirizine
10/26/2005EP1063999B1 Epiallopregnanolone in the treatment of cns disorders
10/26/2005CN1688606A Novel immunogenic lipopeptides comprising T-helper and B-cell epitopes
10/26/2005CN1688603A Treatment and prophylaxis with 4-1BB-binding agents
10/26/2005CN1688578A Phosphodiesterase 4 inhibitors
10/26/2005CN1688553A Chemical process
10/26/2005CN1688548A Process for preparing quinolin antibiotic intermediates
10/26/2005CN1688527A Fused benzene derivative and use
10/26/2005CN1224624C 1, 8-naphthyridin-2 (1H)-one derivatives
10/26/2005CN1224623C 1-phenysulfonyl-1, 3-dihydro-2H-indole-2-one derivatives, their preparation and their therapeutic use
10/26/2005CN1224614C Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
10/26/2005CN1224479C Mathod for preparing micro powder containing anti-agglomerated nanometer silver, micro powder produced by the mathod
10/26/2005CN1224414C Suppository for treating gynecopathy and its preparation technology
10/26/2005CN1224394C Use for saponin of Chinese aralia in preparation of dysmenorrhea medicine
10/25/2005US6958344 Pyrimidine compounds and their use as modulators of chemokine receptor activity
10/25/2005US6958331 sulfonyl amine derivatives such as {2-(2,2-diphenyl-ethylamino)-5-[4-(4-isopropyl-piperazine-1-carbonyl)-piperidine-1-sulfonyl]-phenyl}-morpholin-4-yl-methanone; pain, inflammation, septic shock
10/25/2005US6958326 Estrogen complexes; stabilization
10/25/2005CA2359708C Ketolide antibiotics
10/25/2005CA2331009C Compositions and methods of treatment for conditions responsive to testosterone elevation
10/25/2005CA2227887C Pharmaceutical compositions of conjugated estrogens and methods for their use
10/25/2005CA2147056C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
10/25/2005CA2110454C 1,5,7-trisubstituted indoline compounds for the treatment of dysuria
10/20/2005WO2005097814A2 Composition and method for inhibiting platelet aggregation
10/20/2005WO2005097803A1 Novel water-soluble prodrug
10/20/2005WO2004100501A3 Aggregate radiated power control for multi-band/multi-mode satellite radiotelephone communications systems and methods
10/20/2005WO2002097033A3 Antibodies that immunospecifically bind to trail receptors
10/20/2005US20050235374 Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method
10/20/2005US20050234245 Estrogen receptor modulators
10/20/2005US20050234129 Salts of nateglinide
10/20/2005US20050234118 Novel aryllimidazole derivatives, preparation and therapeutic used thereof
10/20/2005US20050234088 Urea substituted imidazoquinoline ethers
10/20/2005US20050234082 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/20/2005US20050234079 Novel crystalline form of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl]methoxy] benzyl]thiazolidine-2,4-dione potassium salt
10/20/2005US20050234077 Pyrimidine compounds and their use as modulators of chemokine receptor activity
10/20/2005US20050234062 Such as 2-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,8,8a-tetrahydro-1H-phthalazin-2-yl]-piperidin-1-yl}-2H-acetamide; phosphodiesterase inhibitors; for treatment of respiratory disorders
10/20/2005US20050234061 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/20/2005US20050234051 5-Substituted 2-aryl-4 pyrimidinones
10/20/2005US20050234029 Compounds
10/20/2005US20050234028 solid dosage form for contraceptives and hormone replacement therapy; very low moisture content to prevent ester hydrolysis; enhanced bioavailability of 17-beta-estradiol
10/20/2005US20050234022 Use of 2-alkoxyphenyl-substituted imidazotriazinones
10/20/2005US20050233951 Novel two gonadotropin releasing hormones and a method to isolate the same
10/20/2005US20050233943 Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
10/20/2005US20050232870 Method of treatment of dopamine-related dysfunction
10/20/2005CA2563502A1 Novel water-soluble prodrug
10/20/2005CA2561958A1 Composition and method for inhibiting platelet aggregation
10/20/2005CA2560967A1 1-(1h-indol-1-yl)-3-(4-methylpiperazin-1-yl)-1-phenyl propan-2-ol derivatives and related compounds as modulators of the norepinephrine (ne) and the serotonine (5-ht) activity andthe monoamine reuptake for the treatment of vasomotor symptoms (vms)
10/20/2005CA2560966A1 Heterocyclic phenylaminopropanol derivatives as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (vms)
10/20/2005CA2560727A1 Sequential sprm/progestin treatment
10/20/2005CA2557850A1 Methods of treatment using eszopiclone
10/19/2005EP1586581A2 Non-Mammalian GnRH analogs and uses thereof in regulation of fertility and pregnancy
10/19/2005EP1586309A1 Polymeric delivery formulations of leuprolide with improved efficacy
10/19/2005EP1414837B1 Adenosine a3 receptor agonists
10/19/2005EP1339415A4 The composition of multipurpose high functional alkaline solution composition, preparation thereof, and for the use of nonspecific immunostimulator
10/19/2005EP1311263B1 Fused pyrrolocarbazoles against inflammation
10/19/2005EP1292618B1 Vip-related peptides for the treatment of sexual disorders in women
10/19/2005EP1255740B1 Substituted arylpyrazines
10/19/2005EP1250138B1 Fulvestrant formulation
10/19/2005EP1240142B1 New modulators of dopamine neurotransmission
10/19/2005EP1216059B1 Composition for ivf
10/19/2005CN1684737A Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method
10/19/2005CN1684709A Medicine carrier for local application
10/19/2005CN1684673A Electrospun amorphous pharmaceutical compositions
10/19/2005CN1683003A Medicine for treating male anti-sperm antibody yang deficiency patient and its preparing process
10/19/2005CN1683002A Medicine for treating male anti-sperm antibody yin defiency patient and its preparing process
10/19/2005CN1682986A Chinese medicine composition for treating urogenital system disease and its preparing method and use
10/19/2005CN1682977A Wujibaifeng soft capsule and its preparing process
10/19/2005CN1682976A Chinese medicine granular agent for promoting blood circulation and removing blood stasis, removing toxic substance and promoting subsidence of swelling
10/19/2005CN1682975A Medicine for treating pelvic inflammation and its producing method
10/19/2005CN1682969A Medicinal composition and its preparing method and quality control method
10/19/2005CN1682966A Yunnan Manyleaf paris Rhizome extract ora disintegration tablet and its preparing process
10/19/2005CN1682964A Medicine for treating oviduct blocking caused by salpingitis and its preparing process
10/19/2005CN1682963A Medicine for treating endometriosis and its preparing process
10/19/2005CN1682940A 黑膏 Black cream
10/19/2005CN1682937A Medicine for treating mammary gland lobule proliferation and its preparing process
10/19/2005CN1682921A Huoliguan dripping pill for tonifying heart and kidney and its preparing method
1 ... 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 ... 557